LinXis Biopharmaceuticals

Over LinXis Biopharmaceuticals

We designed Fibrobodies®. These proprietary proteins bind selectively to so-called activated myofibroblasts in any type of fibrotic tissue. Fibrobodies® support conjugation of a wide range of payloads to create Fibrobody®-drug Conjugates. We are developing a line-up of Fibrobody®-drug conjugates for the diagnosis and treatment of fibrosis of the liver, kidney, lung and gut.

Trefwoorden

• Antibody-Drug Conjugates (Adcs)
• Coordination Chemistry
• Nanobody-Drug Conjugates (Ndcs)
• Pt-Linker (Lx)

Adres

• Hoofdkantoor

  Cronenburg 751081GM AmsterdamNoord-Holland, Nederland

Team per functiegebied

Gebaseerd op 19 openbare functieprofielen, stand van 3 september 2026.

• Research / R&D9
• Executive / C-Suite3
• Healthcare / Medical3
• Other / Unclassifiable2
• Finance / Accounting1
• Manufacturing / Production1